Public Health England, Porton Down, UK.
Methods Mol Biol. 2022;2414:341-362. doi: 10.1007/978-1-0716-1900-1_18.
Complement is a key component of functional immunological assays used to evaluate vaccine-mediated immunity to a range of bacterial and viral pathogens. However, standardization of these assays is complicated due to the availability of a human complement source that lacks existing antibodies acquired either through vaccination or natural circulation of the pathogen of interest. We have developed a method for depleting both IgG and IgM in 200 mL batches from pooled hirudin-derived human plasma by sequential affinity chromatography using a Protein G Sepharose column followed by POROS™ CaptureSelect™ IgM Affinity resin. The production of large IgG- and IgM-depleted batches of human plasma that retains total hemolytic and alternative pathway activities allows for improved assay standardization and comparison of immune responses in large clinical trials.
补体是用于评估疫苗介导的针对一系列细菌和病毒病原体的免疫反应的功能免疫分析的关键组成部分。然而,由于缺乏通过疫苗接种或感兴趣的病原体的自然循环获得的现有抗体的人类补体来源,这些分析的标准化变得复杂。我们已经开发了一种方法,可以通过使用 Protein G Sepharose 柱进行顺序亲和层析,然后使用 POROS™CaptureSelect™IgM 亲和树脂,从汇集的水蛭素衍生的人血浆中批量去除 200 mL 的 IgG 和 IgM。大量 IgG 和 IgM 耗尽的人血浆批次的生产保留了总溶血和替代途径活性,这使得分析的标准化得到了改善,并能够在大型临床试验中比较免疫反应。